Paul Edward Kelly is Director at RELMADA THERAPEUTICS, INC. (RLMD). They have made 15 open-market trades across 1 company since 2015, most recently 2025-11-05.
CIK 0001658544
8 open-market purchases totalling $963K since 2015, against 7 sales. Across 8 scored buys the stock is up 0.8% at ninety days, and 3.3 points behind the S&P over the same stretch.
8 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| RLMD | 502,295 | $1.6M |
Shares reported on the most recent Form 4, priced at the 2025-11-06 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 75% | 75% | 88% |
| Avg Move | +99.5% | +8.2% | +0.8% |
| Alpha | +89.7% | +8.2% | -3.3% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RLMD | BUY | 2025-11-05 | 2025-11-06 | $2.20 | $396K | +64.2% | +60.4% | +40.4% |
| RLMD | BUY | 2025-05-16 | 2025-05-20 | $0.43 | $86K | +9.0% | +4.4% | +2.2% |
| RLMD | BUY | 2024-09-09 | 2024-09-11 | $2.59 | $65K | -0.6% | -6.0% | -86.7% |
| RLMD | SELL | 2022-04-04 | 2022-04-05 | $30.04 | $300K | -13.0% | -24.1% | -34.7% |
| RLMD | SELL | 2021-03-09 | 2021-03-11 | $35.71 | $357K | -3.2% | +0.5% | -13.8% |
| RLMD | SELL | 2021-02-24 | 2021-02-26 | $34.17 | $338K | +3.0% | -3.5% | +7.3% |
| RLMD | SELL | 2021-02-08 | 2021-02-10 | $35.22 | $199K | +0.9% | +4.9% | -0.1% |
| RLMD | SELL | 2021-02-01 | 2021-02-03 | $35.04 | $163K | +11.8% | -0.5% | +10.1% |
| RLMD | SELL | 2021-01-27 | 2021-01-29 | $32.45 | $319K | +6.9% | +3.1% | +18.8% |
| RLMD | SELL · 10b5-1 | 2021-01-22 | 2021-01-26 | $19.78 | $81K | -0.5% | -0.5% | +9.8% |
| RLMD | SELL | 2021-01-22 | 2021-01-27 | $35.43 | $64K | +9.1% | +4.0% | +20.9% |
| RLMD | BUY | 2019-10-18 | 2019-10-21 | $19.14 | $96K | -3.4% | -4.4% | +38.9% |
| RLMD | BUY | 2019-05-14 | 2019-05-15 | $1.50 | $150K | +181.7% | +2.9% | +2.9% |
| RLMD | BUY | 2018-12-11 | 2018-12-11 | $1.21 | $6K | +181.7% | +2.9% | +2.9% |
| RLMD | BUY | 2018-10-12 | 2018-10-19 | $0.90 | $135K | +181.7% | +2.9% | +2.9% |
| RLMD | BUY | 2015-12-14 | 2015-12-16 | $2.91 | $29K | +181.7% | +2.9% | +2.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.